Cargando…

T-type calcium channel modulation by hydrogen sulfide in neuropathic pain conditions

Neuropathic pain can appear as a direct or indirect nerve damage lesion or disease that affects the somatosensory nervous system. If the neurons are damaged or indirectly stimulated, immune cells contribute significantly to inflammatory and neuropathic pain. After nerve injury, peripheral macrophage...

Descripción completa

Detalles Bibliográficos
Autores principales: Rangel-Galván, Maricruz, Rangel-Galván, Violeta, Rangel-Huerta, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387653/
https://www.ncbi.nlm.nih.gov/pubmed/37529702
http://dx.doi.org/10.3389/fphar.2023.1212800
_version_ 1785081931182899200
author Rangel-Galván, Maricruz
Rangel-Galván, Violeta
Rangel-Huerta, Alejandro
author_facet Rangel-Galván, Maricruz
Rangel-Galván, Violeta
Rangel-Huerta, Alejandro
author_sort Rangel-Galván, Maricruz
collection PubMed
description Neuropathic pain can appear as a direct or indirect nerve damage lesion or disease that affects the somatosensory nervous system. If the neurons are damaged or indirectly stimulated, immune cells contribute significantly to inflammatory and neuropathic pain. After nerve injury, peripheral macrophages/spinal microglia accumulate around damaged neurons, producing endogenous hydrogen sulfide (H(2)S) through the cystathionine-γ-lyase (CSE) enzyme. H(2)S has a pronociceptive modulation on the Ca(v)3.2 subtype, the predominant Ca(v)3 isoform involved in pain processes. The present review provides relevant information about H(2)S modulation on the Ca(v)3.2 T-type channels in neuropathic pain conditions. We have discussed that the dual effect of H(2)S on T-type channels is concentration-dependent, that is, an inhibitory effect is seen at low concentrations of 10 µM and an augmentation effect on T-current at 100 µM. The modulation mechanism of the Ca(v)3.2 channel by H(2)S involves the direct participation of the redox/Zn(2+) affinity site located in the His191 in the extracellular loop of domain I of the channel, involving a group of extracellular cysteines, comprising C114, C123, C128, and C1333, that can modify the local redox environment. The indirect interaction pathways involve the regulation of the Ca(v)3.2 channel through cytokines, kinases, and post-translational regulators of channel expression. The findings conclude that the CSE/H(2)S/Ca(v)3.2 pathway could be a promising therapeutic target for neuropathic pain disorders.
format Online
Article
Text
id pubmed-10387653
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103876532023-08-01 T-type calcium channel modulation by hydrogen sulfide in neuropathic pain conditions Rangel-Galván, Maricruz Rangel-Galván, Violeta Rangel-Huerta, Alejandro Front Pharmacol Pharmacology Neuropathic pain can appear as a direct or indirect nerve damage lesion or disease that affects the somatosensory nervous system. If the neurons are damaged or indirectly stimulated, immune cells contribute significantly to inflammatory and neuropathic pain. After nerve injury, peripheral macrophages/spinal microglia accumulate around damaged neurons, producing endogenous hydrogen sulfide (H(2)S) through the cystathionine-γ-lyase (CSE) enzyme. H(2)S has a pronociceptive modulation on the Ca(v)3.2 subtype, the predominant Ca(v)3 isoform involved in pain processes. The present review provides relevant information about H(2)S modulation on the Ca(v)3.2 T-type channels in neuropathic pain conditions. We have discussed that the dual effect of H(2)S on T-type channels is concentration-dependent, that is, an inhibitory effect is seen at low concentrations of 10 µM and an augmentation effect on T-current at 100 µM. The modulation mechanism of the Ca(v)3.2 channel by H(2)S involves the direct participation of the redox/Zn(2+) affinity site located in the His191 in the extracellular loop of domain I of the channel, involving a group of extracellular cysteines, comprising C114, C123, C128, and C1333, that can modify the local redox environment. The indirect interaction pathways involve the regulation of the Ca(v)3.2 channel through cytokines, kinases, and post-translational regulators of channel expression. The findings conclude that the CSE/H(2)S/Ca(v)3.2 pathway could be a promising therapeutic target for neuropathic pain disorders. Frontiers Media S.A. 2023-07-17 /pmc/articles/PMC10387653/ /pubmed/37529702 http://dx.doi.org/10.3389/fphar.2023.1212800 Text en Copyright © 2023 Rangel-Galván, Rangel-Galván and Rangel-Huerta. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Rangel-Galván, Maricruz
Rangel-Galván, Violeta
Rangel-Huerta, Alejandro
T-type calcium channel modulation by hydrogen sulfide in neuropathic pain conditions
title T-type calcium channel modulation by hydrogen sulfide in neuropathic pain conditions
title_full T-type calcium channel modulation by hydrogen sulfide in neuropathic pain conditions
title_fullStr T-type calcium channel modulation by hydrogen sulfide in neuropathic pain conditions
title_full_unstemmed T-type calcium channel modulation by hydrogen sulfide in neuropathic pain conditions
title_short T-type calcium channel modulation by hydrogen sulfide in neuropathic pain conditions
title_sort t-type calcium channel modulation by hydrogen sulfide in neuropathic pain conditions
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387653/
https://www.ncbi.nlm.nih.gov/pubmed/37529702
http://dx.doi.org/10.3389/fphar.2023.1212800
work_keys_str_mv AT rangelgalvanmaricruz ttypecalciumchannelmodulationbyhydrogensulfideinneuropathicpainconditions
AT rangelgalvanvioleta ttypecalciumchannelmodulationbyhydrogensulfideinneuropathicpainconditions
AT rangelhuertaalejandro ttypecalciumchannelmodulationbyhydrogensulfideinneuropathicpainconditions